Literature DB >> 16755511

DBCollHIV: a database system for collaborative HIV analysis in Brazil.

Luciano V Araújo1, Marcelo A Soares, Suelene M Oliveira, Pedro Chequer, Amilcar Tanuri, Ester C Sabino, João E Ferreira.   

Abstract

We developed a database system for collaborative HIV analysis (DBCollHIV) in Brazil. The main purpose of our DBCollHIV project was to develop an HIV-integrated database system with analytical bioinformatics tools that would support the needs of Brazilian research groups for data storage and sequence analysis. Whenever authorized by the principal investigator, this system also allows the integration of data from different studies and/or the release of the data to the general public. The development of a database that combines sequences associated with clinical/epidemiological data is difficult without the active support of interdisciplinary investigators. A functional database that securely stores data and helps the investigator to manipulate their sequences before publication would be an attractive tool for investigators depositing their data and collaborating with other groups. DBCollHIV allows investigators to manipulate their own datasets, as well as integrating molecular and clinical HIV data, in an innovative fashion.

Mesh:

Year:  2006        PMID: 16755511

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  2 in total

1.  ORION-VIRCAT: a tool for mapping ICTV and NCBI taxonomies.

Authors:  Willy Valdivia-Granda; Francis Larson
Journal:  Database (Oxford)       Date:  2009-10-12       Impact factor: 3.451

2.  HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection.

Authors:  Natália Mirele Cantão; Lauana Fogaça de Almeida; Ivan Rodrigo Wolf; Rodrigo Oliveira Almeida; Andressa Alves de Almeida Cruz; Caroline Nunes; Alexandre Naime Barbosa; Guilherme Targino Valente; Maria Inês de Moura Campos Pardini; Rejane Maria Tommasini Grotto
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.